Contractor profile
WE PHARMA, INC.
Doing business as WEP CLINICAL
Active registrationSelf Certified Small Disadvantaged BusinessSmall Business
UEIEWAMVJSFNK29
CAGE code7CN54
Primary NAICS424210
LocationMORRISVILLE, NC, 27560
Federal obligations$3M
Prime awards8
Active awards3
Latest award actionJul 24, 2026
Federal award activity
Public award recordTop federal customers
- Department of Health and Human Services8 awards$3M
NAICS award mix
- 4242103 awards$2M
- 3254125 awards$1M
PSC award mix
- Q9993 awards$2M
- 65055 awards$1M
Contract vehicles
- 75F40121D000182 awards$2M
- 75F40120D000324 awards$1M
Potential recompetes
- Department of Health and Human Services$75,000
- Department of Health and Human Services$300,000
- Department of Health and Human Services$2M
Prime award history
| Award | Agency / office | Category | Value | Dates |
|---|---|---|---|---|
| 75F40123F19003PHARMACEUTICAL PRODUCTS FOR FDA/OPQ DOMESTIC MANUFACTURING AND REGULATORY PURPOSES. | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 424210PSC Q999 | $213,614 | Mar 23, 2023 – Sep 30, 2023 |
| 75F40121D00018THE CONTRACTOR SHALL PROVIDE THE FDA WITH THE FOLLOWING: I. PRODUCTS LISTED IN ATTACHMENT 1 (PHARMACEUTICAL PRICING LIST), IN RESPONSE TO GOVERNMENT ORDERS. AT A MINIMUM, THIS TABLE WILL BE UPDATED ONCE A YEAR. II. SUPPLY EMERGENCY OVERNIGHT DELI | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 424210PSC Q999 | $0 | Jun 25, 2021 – Not stated |
| 75F40125F19004TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR). | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 424210PSC Q999 | $2M | Jul 28, 2025 – Aug 6, 2030 |
| 75F40125F19011PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES. | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 325412PSC 6505 | $300,000 | Sep 16, 2025 – Sep 16, 2026 |
| 75F40123F19008PHARMACEUTICAL DRUG PRODUCT ORDERS | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 325412PSC 6505 | $399,561 | Jul 31, 2023 – Aug 6, 2024 |
| 75F40118P20106PHYSICOCHEMICAL PRODUCTS | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 325412PSC 6505 | $214,915 | Jun 29, 2018 – Jul 15, 2020 |
| 75F40125F19010PHARMACEUTICAL DRUG PRODUCTS | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 325412PSC 6505 | $75,000 | May 14, 2025 – Nov 13, 2026 |
| 75F40124F19009TASK ORDER AGAINST IDIQ 75F40120D00032 FOR PHARMACEUTICAL DRUG PRODUCTS. | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | NAICS 325412PSC 6505 | $357,000 | Apr 25, 2024 – Aug 6, 2025 |
Award links and obligation totals come from USAspending.gov public records.
Industries and classifications
Public points of contact
DAVID THACKERGovernment business
DAVID THACKERGOVERNMENT ACCOUNT MANAGERAlternate government business
MATTHEW COMSTOCKVP OF BDElectronic business
ROBERT POWELLSR. DIRECTOR-COMPARATOR/CTS SOURCINGAlternate electronic business
Names and titles are reproduced from the public registration. FedRoster does not guess or enrich personal contact details.